PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-03-25

Date Title Company
25-Mar-2025 Santhera to share latest on commercial rollout of AGAMREE® and future strategic priorities at Capital Markets Day Santhera Pharmaceuticals
25-Mar-2025 Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs Coronado Research
25-Mar-2025 Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. Genmab
25-Mar-2025 CAS announces the participants selected for the 2025 CAS Future Leaders program CAS
25-Mar-2025 WWF launches five-year partnership with GSK WWF
25-Mar-2025 Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities Alcon
25-Mar-2025 Alcon Agrees to Acquire LENSAR, Inc. Alcon
25-Mar-2025 Cinven completes sale of minority stake in SYNLAB to strategic investor Labcorp Labcorp
25-Mar-2025 Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease Abbott
25-Mar-2025 The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist Novo Nordisk
25-Mar-2025 GSK, UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to collaborate on first-of-its-kind dementia research initiative GSK
25-Mar-2025 GSK’s application to expand use of Nucala (mepolizumab) for the treatment of COPD accepted for review by the European Medicines Agency GSK
25-Mar-2025 New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings AstraZeneca
25-Mar-2025 Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square Biogen
25-Mar-2025 Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities Eckert & Ziegler SE
25-Mar-2025 Medical Holography Market Technological Advancements and Revenue Analysis Report 2024 to 2029 Medi-Tech Insights
25-Mar-2025 Medios expects further growth in revenue and earnings after record year 2024 Medios AG
25-Mar-2025 Medacta Group SA: Medacta Group SA reports an excellent performance in 2024 with an adjusted EBITDA margin1 in constant currency of 28.0% Medacta Group SA
25-Mar-2025 Straumann Group to present its advanced digital dentistry end-to-end workflow at the International Dental Show in Cologne Straumann Holding AG
25-Mar-2025 SKAN with significant profit increase and strong order intake in the 2024 financial year SKAN AG